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Kashin-Beck disease (KBD) is an endemic chronic osteochondropathy. The 
etiology of KBD remains unknown. In this study, we conducted an 
integrative analysis of genome-wide DNA methylation and mRNA 
expression profiles between KBD and normal controls to identify novel 
candidate genes and pathways for KBD. Articular cartilage samples from 17 
grade III KBD patients and 17 healthy controls were used in this study. 
DNA methylation profiling of knee cartilage and mRNA expression profiles 
data were obtained from our previous studies. InCroMAP was performed 
to integrative analysis of genome-wide DNA methylation profiles and 
mRNA expression profiles. Gene ontology (GO) enrichment analysis was 
conducted by online DAVID 6.7. The quantitative real-time polymerase 
chain reaction (qPCR), Western blot, immunohistochemistry (IHC), and 
lentiviral vectors transfection were used to validate one of the identified 
pathways. We identified 298 common genes (such as COL4A1, HOXA13, 
TNFAIP6 and TGFBI), 36 GO terms (including collagen function, skeletal 
system development, growth factor), and 32 KEGG pathways associated 
with KBD (including Selenocompound metabolism pathway, PI3K-Akt 
signaling pathway and TGF-beta signaling pathway). Our results suggest 
the dysfunction of many genes and pathways implicated in the 
pathogenesis of KBD, most importantly, both the integrative analysis and in 
vitro study in KBD cartilage highlighted the importance of selenocompound 
metabolism pathway in the pathogenesis of KBD for the first time. 
 




Kashin-Beck disease (KBD) is an endemic chronic osteochondropathy, 
distributed in certain areas of Eastern Siberia of Russia, North Korea and 
China (Guo et al., 2014). According to China Health Statistics Yearbook, 37.9 
million people living at KBD prevalent counties are at the risk of KBD, and 
0.53 million patients suffered from KBD in China in 2017, including 8,540 
children under the age of 16. KBD mainly damages cartilage, especially in 
growth plate and joints (Moreno-Reyes et al., 1998). It usually occurs during 
childhood between 3 and 12 years and becomes symptomatic in adulthood. 
The typical manifestations of KBD include serious joint pain, joint deformities, 
irreversible aggravated osteoarthritis(OA) and growth retardation (Lu et al., 
2011). 
Various etiological hypotheses have been proposed for KBD, mainly 
including environmental selenium deficiency and cereal contamination by 
myco-toxin-producing fungi (mainly for T-2 toxin) (Guo et al., 2014). In the 
1970’s, Chinese researchers discovered that a low environmental content of 
selenium resulted in a poor nutritional selenium uptake in the KBD prevalent 
areas (Guo et al., 2014). Selenium is an essential element for human health and 
relates to many diseases, such as cancer, cardiovascular, diabetes, especially 
Keshan Disease (KD) and KBD (Guo et al., 2014). KBD is distributed in 
selenium deficient areas in a diagonal belt from northeast to southwest China 
in the KBD endemic areas, the level of selenium in both soil and human 
biological samples are in lower amounts than non-KBD areas. The hair 
selenium level of school children in KBD prevalent areas are significantly 
lower than that of children living in non-KBD prevalent areas (Chen et al., 
2015). Consequently, selenium deficiency is an endemic risk factor for KBD, 
but the mechanism of environmental selenium deficiency implicated in the 
pathogenesis of KBD remains elusive. Besides, T-2 toxin has been identified in 
endemic food samples in KBD prevalent areas. The chicks fed with food 
contaminated by T-2 toxin have shown the similar cartilage damages with 
KBD patients (Li et al., 2016). Therefore, T-2 toxin has been used as toxic 
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treatment in human chondrocyte line (C28/I2) for years to simulate the similar 
mechanism in KBD chondrocytes (X. Wang et al., 2017b).  
Benefiting from the rapid development of high throughput analyzing 
technologies, several genomic studies of KBD samples identified multiple 
genes associated with KBD. For instance, genetic association studies identified 
HLA-DRB1 (S. Luo et al., 2016) and ITPR2 (F. Zhang et al., 2015a) are 
susceptibility genes for KBD. Gene expression profiles analysis identified 79 
differently expressed genes between KBD and normal cartilage (W. Z. Wang et 
al., 2009). DNA methylation is the most extensively studied epigenetic 
modulation (Y. Zhang et al., 2016). Recent studies demonstrated that abnormal 
DNA methylation was strongly correlated with cartilage damage in OA. 
Roach et al. (Roach et al., 2005) confirmed that epigenetic changes contributed 
to the altered synthesis of cartilage degrading enzymes in the chondrocytes of 
late stage OA patients. Jeffries et al. (Jeffries et al., 2016) observed abnormal 
methylation of OA susceptibility genes associated with both OA subchondral 
bone and cartilage. However, the role and mechanism of DNA methylation in 
the development of KBD is still nebulous. 
It is acknowledged that traditional single omic (for instance, genome or 
transcriptome) mostly could not unveil the elusive molecular mechanisms of 
complex diseases. Therefore, integrative multi-omics datasets is becoming 
valuable. It could not only lead to lower false discovery rates, but also provide 
more biological insights than single omic analysis (Bonnet et al., 2015; M. Kim 
et al., 2016). Moreover, this method could reveal the biological complexity and 
overcome the weakness of single omics, the lack of comprehensiveness and the 
information gap regarding interacting across multiple omic layers (Yugi et al., 
2016). By using tans-omics integrative strategy, many studies have uncovered 
the implicate dysfunction of multiple molecular levels in complex diseases. 
Several tools for users to integrate the different omics are widely used now, 
such as InCroMAP (Cambiaghi et al., 2017; Wrzodek et al., 2013), a powerful, 
high-level cross-platform microarray dataset analysis tool for generic or 




In this study, we performed integrating analysis of DNA methylation 
profiles and mRNA expression profiling of KBD and normal cartilage to 
identify novel candidate genes and pathways for KBD. Our results suggest the 
dysfunction of many genes and pathways are implicated in the pathogenesis 
of KBD. Most importantly, both the integrative analysis and in vitro study in 
KBD cartilage highlighted the importance of selenocompound metabolism 
pathway in the pathogenesis of KBD for the first time. 
Materials and Methods 
Ethical approval 
This investigation was approved by the Human Ethics Committee of Xi’an 
Jiaotong University (Project Number: 2015-237). The study was conducted in 
accordance with the ethical standards as laid down in the 1964 Declaration of 
Helsinki and its later amendments or comparable ethical standards. A written 
informed consent was obtained from all the patients or relatives of donors. 
Sample collection 
Human articular cartilage samples from 17 grade III KBD and 17 normal 
controls were used in this study (Table 1). Both KBD and normal subjects were 
of Chinese Han lineage and matched with age. KBD was diagnosed according 
to the diagnosis criteria of KBD in China (WS/T 207-2010). Clinical and 
radiography examination were taken carefully for each subject. Other 
demographic characteristics of human subjects such as lifestyle habits, family 
history, heath status and ethnicities were collected from nurse-administered 
questionnaires. The subjects with genetic bone and cartilage diseases, 
rheumatoid arthritis (RA) and other skeletal disorders were excluded from this 
study. 
Genome-wide DNA methylation profiling 
The cartilage specimens of 5 KBD and control pairs were harvested from knee 
joints (W. Wang et al., 2017a). QIAamp DNA Blood Mini Kit (QIAGEN, 
Germany) was used to extract DNA from the cartilage specimens according to 
the manufacturer’s recommendations. Samples were dissected and frozen in 
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liquid nitrogen rapidly for genome-wide DNA methylation profiling. The 
quality of extracted DNA was evaluated by agarose gel electrophoresis. 
Illumina Infinium HumanMethylation450 BeadChip was used for 
genome-wide DNA methylation profiling. A total of 500ng DNA was used for 
bisulfite conversion according to the standard protocol for the EZ DNA 
Methylation Kit (Zymo Research, USA). Then, the samples were incubated 
overnight at 37℃ followed by the addition of whole genome amplification. 
After that, we use HumanMethylation450 array for hybridizaetion, the array 
was washed and stained following the protocol guide of Infinium HD Assay 
Methylation. Then IScan SQ scanner (iScan System, Illumina, USA) was used 
for scanning the raw image intensities. The obtained raw data of image 
intensity was processed using GenomeStudio software (Illumina, USA).  
Differential methylation analysis 
A β value, varying from 0 (completely unmethylated) to 1 (completely 
methylated), was defined as the expression of the average percentage of 
methylated cytosine at a given CpG site. Differentially methylated CpG sites 
were identified using the empirical Bayes moderated t-test in limma (Ritchie et 
al., 2015), which was described by Illumina Methylation Analyzer package. A 
false discovery rate (FDR) adjusted P value for each CpG site was calculated by 
using Benjiamini-Hochberg method. The Pearson correlation coefficients were 
calculated to evaluate the correlations of cartilage specimens. 
For quality control, the quality of extracted DNA was evaluated by 
agarose gel electrophoresis. The DNA specimens passing the quality control 
were used for DNA methylation profiling. The definition of significant CpG 
met the following two conditions: (1) FDR adjusted P value (Padj) ≤ 0.05; (2) |β 
difference (∆β)| ≥ 0.2. The CpG sites with Padj＞0.05, or Padj ≤ 0.05 with missing 
values in more than 90% of cartilage specimens accompanied by P＞0.05 were 
eliminated.  
Gene expression profiling of KBD and normal cartilage 
Our previous gene expression profiling of KBD and normal cartilage were 
used here (W. Z. Wang et al., 2009). In brief, the articular cartilages of 4 KBD 
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patients and 4 normal controls were collected and matched according to age 
and sex. 4 KBD patients from Yongshou County and Linyou County of Xi’an 
city in China underwent free total knee replacement surgery, and their 
articular cartilage tissues were collected. 4 matched healthy control knee 
cartilage samples were collected from the donors within 8 hours of death 
caused by traffic accidents, the status of healthy samples were diagnosed by 
histological examination with H&E staining, for excluding KBD, genetic bone, 
cartilage diseases, OA and RA. Detailed procedures for the experiment were 
described in our previous study (W. Z. Wang et al., 2009). 
Integrated analysis of DNA methylation and mRNA expression profiles 
The DNA methylation and mRNA expression profiling datasets were input 
into InCroMAP for integrated analysis. Before running analysis, the filtering 
thresholds of InCroMAP were set as p-value <0.05 for DNA methylation 
profile data and fold-change (FC) ≥1.5 for mRNA expression profile data. After 
input the uniform data required by InCroMAP, integration of multiple data 
types was performed by mapping each probe to every individual gene. This 
process is straightforward for mRNA datasets, while DNA methylation 
datasets are region based on genes by defining the upstream and downstream 
of each gene’s transcription start site (Wrzodek et al., 2013). On the basis of 
data-pairing, the common genes altered both in DNA methylation profiles 
and mRNA expression profiles were identified. InCroMAP supports gene sets 
from the KEGG PATHWAY database. It could also visualize all the pathways 
by using KEGG translator. Therefore, the mRNA expression or protein 
modification’s expression value were highlighted by node color or small box. 
After that, KEGG pathway database provided by InCroMAP was used for 
pathway enrichment analysis in this study (Wrzodek et al., 2013). At last, the 
identified common genes were submitted to the DAVID 6.7 functional 
annotation analysis tool (http://david.abcc.ncifcrf.gov) for Gene Ontology 
(GO) enrichment analysis. 
Primary chondrocyte isolation and culture 
In order to confirm involvement of specific genes determined by the 
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integrated analysis of DNA methylation and mRNA expression profiles, we 
used an in vitro cell model of KBD. The human chondrocyte line (C28/I2), 
obtained from Mary B. Goldring (Claassen et al., 2011), treated with T-2 
toxin(X. Wang et al., 2017b) for detecting the mRNA expression of significant 
genes. Then, another independent human articular chondrocytes samples 
from 8 grade III KBD patients and 8 normal controls of femoral neck fracture 
(FNF) were used for Western blot (5 pairs) and immunohistochemistry (IHC) 
(3 pairs) to identify the expression of SEPSECS protein in KBD articular 
cartilage (Table 1). 
KBD and control cartilage samples were cut into 5-10 mm3 slices, treated 
with 0.25% trypsin (Xi’an GuoAn Biological Techonology Co.) for 30 minutes 
at room temperature (RT) and immersed into 0.2% type II collagenase 
solution (Gibco, 17101-015) at 37℃ for 10 hours. After that, the isolated 
chondrocytes were cultured at 37℃ in 5% CO2 in DMEM/F12 supplemented 
with 10% fetal calf serum (Sijiqing, Zhejiang Tianhang Biotechnology 
Company, Hangzhou, China) and 1% penicillin/streptomycin. 
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide, 
Thiazolyl Blue Tetrazolium Bromide (MTT) assay  
C28/I2 cell line was cultured at 37℃ in 5% CO2 in DMEM/F12 supplemented 
with 10% fetal calf serum and 1% penicillin/streptomycin. C28/I2 and T-2 
toxin were used to make the KBD cell models as described previously (X. 
Wang et al., 2017b). We used MTT assay to determine the cytotoxicity in 
C28/I2 human chondrocytes after treated with T-2 toxin. C28/I2 human 
chondorcytes were seeded in 96-well plates and treated with T-2 toxin at 8 
different concentrations (1, 2, 5, 8, 10, 12, 15, 20ng/ml) for 12h, 24h, 48h and 
72h separately. Each concentration has 5 repeats. Then, 20ul of MTT (5ng/ml) 
was added in each wells for 4 hours. After that, the medium was discarded 
and 200ul dimethyl sulfoxide (DMSO) was added to dissolve the formazan. 
The results were measured by an automatic enzyme-linked immunosorbent 
assay reader at 490nm (X. Wang et al., 2017b).  
Quantitative real-time polymerase chain reaction (qPCR) 
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Total RNA from C28/I2 and T-2 toxin (treated C28/I2 cells 2ng/ml, 5ng/ml, 
8ng/ml for 24h) isolated according to TRIzol protocol and reverse-transcribed 
to cDNA by One step TaKaRa PrimeScriptTM RT reagent Kit. GAPDH was 
chosen as reference gene (X. Wang et al., 2017b). mRNA expression of 
identified genes (CTH, SEPSECS and PAPSS2) from Selenocompound 
metabolism pathway were measured by qPCR in triplicate analysis (Table 2). 
The cycle of threshold (CT) of each sample was averaged and normalized to 
that of GAPDH. The triplicate results were analyzed by comparative CT 
equation (2-△△CT). 
Western blot 
Radio immunoprecipitation assay reagent (Xi’an Hat Biotechnology Co., Ltd) 
was used for isolating the protein from KBD and control chondrocyte. The 
concentration of the protein was measured by BCA protein assay kit (Xi’an 
Hat Biotechnology Co., Ltd). Then, proteins were equally added to the 
SDS-polyacrylamid gelectrophoresis (SDS-PAGE) and ran separately before 
transferred to polyvinylidenedifluoride (PVDF) membranes. The PVDF 
membranes were blocked in 5% nonfat milk solution and incubated with the 
SEPSECS primary antibody (1:1000, ab56033, abcam) at 4℃ overnight and the 
secondary antibody (1:5000, Xi’an Zhuangzhi Biotechnology Co., Ltd, Cat: 
EK020) for 1 hour at RT. Gene Gnome XRQ (Gene Co., Ltd) was used to 
analyze the protein bands. 
Immunohistochemistry (IHC) 
The independent 3 grade III KBD patients and 3 control articular cartilage 
samples were used here. First, samples were embedded in paraffin for IHC. 
The procedure includes cutting sections, dewax, rehydrate, and antigen 
retrieval using citrate buffer (pH 6.0) overnight at 37℃ and 12.5% trypsin 
(Xi’an GuoAn Biological Techonology Co.) at 37℃ for 20-30 minutes. Zhong 
Shan Gold Bridge Rabbit SP reagent was used in the following procession 
(Beijing Zhong Shan Gold Bridge Biological Techonology Co., 18112A11). 3% 
H2O2 was used to prevent endogenous peroxidase reactions for 10 minutes at 
RT (white bottle), and serum was used to block the samples for 20 minutes at 
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RT to avoid non-specific background (blue bottle). Then, primary antibody of 
SEPSECS (1:60, ab56033, abcam) treated the samples at 4℃ overnight. The 
slices were rewarmed at 37℃ the next day for 1h at RT before treating with 
secondary antibody (yellow bottle) and horseradish peroxidase (red bottle) 
for 20 minutes at RT, respectively. After that, DAB solution treated the 
sections until the appropriate color could be seen before dehydrating, 
mounting the sections and dyeing the nucleus. 
Lentiviral vectors transfection 
In order to further detect the role of SEPSECS in the mechanism of KBD cell 
model. The recombinant lentivirus of SEPSECS acquired from Genechem 
(Shanghai, China) was used here. C28/I2 human chondrocytes were first 
treated with 8ng/ml T-2 toxin for 24h, after that, the SEPSECS lentivirus and 
negative lentivirus were transfected into C28/I2 for 96h. Then, the mRNA 
expression of SEPSECS and the selected genes (MMP13, SOX9 and ADAMTS5) 
were measured by qPCR (Table 2). 
Statistical analysis 
A one-way analysis of variance (ANOVA) and independent samples t-test 
were used for comparisons of the results. Statistical analyses were performed 
by SPSS 19.0. The threshold was defined as P<0.05. 
Results 
DNA methylation profile 
In total 473,607 methylation sites analyzed across the genome by using 
Illumina Infinium HumanMethylation450 BeadChip and 10,161 methylated 
CpG sites were identified significantly changed (P<0.05) between KBD and 
normal samples, including 4,027 hypermethylation CpG cites (corresponding 
to 1,047 genes) and 6,134 hypomethylation CpG cites (corresponding to 1,747 
genes). Table 3 shows the top 20 significant hypermethylation and 
hypomethylation CpG sites, among which, cg07687119 (P-value=3.11×10-9, 
∆β=0.345) with the target genes (HOXC4, HOXC6 and HOXC5) is the most 
significant hypermethylation locus for KBD. Meanwhile, cg03223172 
(P-value=1.28×10-9, ∆β=-0.294) is the most significant hypomethylation locus 
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for KBD, however, no target gene was identified with this locus. Multiple 
genes were identified significant differentially methylated between KBD and 
normal controls, such as SEPSECS (cg20177285, P-value=3.47×10-5, ∆β=-0.4166), 
TNFAIP6 (cg01189638, P-value=1.33×10-3, ∆β=-0.2732). Some genes are related 
more than one CpG site. For instance, COL4A1 is related to cg00050792 
(P-value=2.07×10-3, ∆β=0.2958), cg08234256 (P-value=9.19×10-3, ∆β=0.2148) 
and cg03564009 (P-value=1.09×10-3, ∆β=0.2948). 
Integrative analysis of DNA methylation profile and mRNA expression 
To reveal the complicated mechanism of KBD, we conducted a genome-wide 
integrative analysis of DNA methylation profiles and mRNA expression 
profiles of KBD and normal cartilage. After considering Gene Bank ID, Pmethyl 
<0.05 (DNA methylated CpG sites) and fold-change (FC) ≥1.5 (mRNA 
expression files), 7,526 methylated CpG cites and 2,400 mRNA expression 
profiles between KBD and normal controls were subjected to the InCroMAP. 
298 commonly affected genes in both DNA methylation profiles and mRNA 
expression profiles between KBD and normal controls were identified 
(Additional File: Table S1). These genes include the collagen family members, 
such as COL1A1 (NM_000088, Pmethyl=4.42×10-3, FC=4.92), COL1A2 
(NM_000089, Pmethyl=2.26×10-3, FC=2.05), COL4A1 (NM_001845, 
Pmethyl=4.12×10-3, FC=2.16), COL4A2 (NM_001846, Pmethyl=8.05×10-3, FC=2.42), 
COL5A2 (NM_000393, Pmethyl=2.09×10-3, FC=5.66), COL9A3 (NM_001853, 
Pmethyl=0.02, FC=2.81) and COL14A1 (NM_021110, Pmethyl=4.47×10-3, FC=1.61), 
and the homeobox family, such as HOXA13 (NM_000522, Pmethyl=0.013, 
FC=1.84), HOXB2 (NM_002145, Pmethyl=1.03×10-3, FC=5.08), HOXC9 
(NM_006897, Pmethyl=9.15×10-3, FC=2.22), and HOXD10 (NM_002148, 
Pmethyl=0.028, FC=1.59), altered both in DNA methylation and mRNA 
expression in KBD cartilage compared to normal controls. Moreover, some 
other genes, such as TNFAIP6 (NM_007115, Pmethyl=1.34×10-3, FC=5.94) and 
TGFBI (NM_000358, Pmethyl=3.21×10-3, FC=7.86), which have been found as 
significant genes in KBD patients previously (Guo et al., 2006; S. Wang et al., 




GO enrichment analysis of these 298 genes identified 36 significantly 
overrepresented GO terms (FDR<0.05), including those functionally involved 
in collagen, skeletal system development, growth factor and apoptosis (Figure 
1, Table S2). 
Integrative pathway enrichment analysis of DNA methylation profiles 
and mRNA expression profiles demonstrated 32 pathways significantly 
associated with KBD (Table 4), such as Selenocompound metabolism pathway 
(KEGG path: hsa00450, P=0.0123, Figure 2), PI3K-Akt signaling pathway 
(KEGG path: hsa04151, P=3.40×10-3, Figure 3), TGF-beta signaling pathway 
(KEGG path: hsa04350, P=4.30×10-3), and Regulation of actin cytoskeleton 
(KEGG path: hsa04810, P=3.95×10-3). 
In vitro confirmation of selected genes 
To ensure there are sufficient cells to perform mRNA expression analysis and 
simulate the similar mechanism of KBD chondrocytes, we used MTT assay to 
follow cell survival rate to response to different concentration of T-2 toxin. 
Our results showed that C28/I2 chondrocyte survival rate were decreased 
with the increasing concentration of T-2 toxin. The median inhibitory 
concentration (IC50) of T-2 toxin treated on C28/I2 for each time point were 
14.90 ng/ml, 11.98 ng/ml, 7.05 ng/ml, 6.52ng/ml for 12h, 24h, 48h and 72h, 
respectively. The least significant difference (LSD) method detected 
significant differences between the 4 different time groups and control 
(F=4.237, P=0.006). 24h, 48h, 72h showed significant differences when 
compared with control (P=0.028, 0.001, 0.001, respectively). Concentration 
analysis identified that T-2 toxin induced significant differences among the 8 
concentration groups (F=3.631, P=0.004). In this study, we chose the 
concentration of T-2 toxin as 2 ng/ml, 5 ng/ml and 8ng/ml for 24h as our best 
protocol to ensure adequate cell response and sufficient cell survival for 
further analysis. 
The mRNA expression of selected genes in KBD cell model 
A set of 3 distinct genes from the significantly affected Selenocompound 
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metabolism pathway were selected and gene expression levels quantified in 
the KBD in vitro model that C28/I2 cell line treated with T-2 toxin (2 ng/ml, 5 
ng/ml and 8ng/ml) for 24h. We observed that the mRNA expression levels of 
3 genes (SEPSECS, CTH and PAPSS2) from the Selenocompound metabolism 
pathway were all significantly increased in C28/I2 chondrocytes treated with 
T-2 comparing with control (PSEPSECS<1.0×10-4, PCTH=4.0×10-3, PPAPSS2=7.2×10-3) 
(Figure 4). 
After treated by 8ng/ml T-2 toxin for 24h in C28/I2 human chondrocytes, 
the mRNA expression of SEPSECS were significantly increased (P<0.001, 
Figure 5A). Then, after knocking out SEPSECS by lentivirus transfection, the 
mRNA expression of SEPSECS were significantly decreased (P<0.001, Figure 
5A), which means the effectiveness of knocking out SEPSECS in C28/I2 
human chondrocytes treated with T-2 toxin. The mRNA expression of 
MMP13 was decreased notably (P<0.001, Figure 5B), while the SOX9 was 
overexpressed after knocking out SEPSECS in C28/I2 human chondrocytes 
(P<0.01, Figure 5C), but the mRNA expression of ADMATS5 had no 
significant different between the lentivirus group and T-2 toxin group (Figure 
5D).  
The expression of SEPSECS in KBD cartilage 
The expression of SEPSECS protein by IHC was observed in the superficial, 
middle, and deep layer of KBD and control articular cartilage. The results 
showed that the expression of SEPSECS protein was significant higher in 
superficial layer of KBD samples compared with control samples (P=0.021), 
while the middle and deep layer showed no significance (Figure 6). In 
addition, western blot results showed that the expression of SEPSECS protein 
(54 kDa) was 2.19 times higher in KBD chondrocytes than that in normal 
controls (P=7.10×10-3) (Figure 7).  
Discussion 
In this study, a trans-omic analysis of DNA methylation and mRNA 
expression profiling between KBD and normal samples was performed by 
using the cross-platform microarray dataset analysis tool InCroMAP. 298 
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common genes, 36 GO terms, and 32 KEGG pathways were identified 
associated with the pathogenesis of KBD.  
    Among all the 298 common genes, we found several genes of the collagen 
type family have significant altered, such as COL1A1, COL1A2, COL4A1, 
COL4A2, COL5A2, COL9A3 and COL14A1. The Collagen family is the most 
abundant proteins in the extracellular matrix (ECM) and is essential for bone 
adhesion and formation. Different collagen types based on molecular defects 
of collagen genes are related to many disorders, such as chondrodysplasias, 
osteogenesis imperfecta, epidermolysis bullosa, OA and osteoporosis (K. Gelse, 
2003). COL4A1 promotes osteoblastic cells survival and ECM formation and is 
related to osteoporosis in KBD patients (Wen et al., 2016). Additionally, Wang 
et al. (S. Wang et al., 2012) demonstrated COL5A2 is a significant gene in KBD 
chondrocytic but not in peripheral blood monocytic networks. Type I collagen 
(COL1) is participated in the repair of articular cartilage (Yanagisawa et al., 
2012). Therefore, we suggested that the candidate genes of COL1A1 and 
COL1A2 may be involved in the cartilage repair of KBD. Since few studies 
have showed collagen family genes (COL1A1, COL1A2, COL4A2, COL9A3, 
COL14A1) identified in this study related to KBD, our findings indicated the 
important roles of collagen family in the molecular mechanism of KBD 
articular cartilage.   
Another interesting series of genes we found related to KBD is homeobox 
family (HOXA13, HOXB2, HOXC9 and HOXD10). Homeobox genes are a 
group of transcription genes that function as the formation of many body 
structures during early embryonic development. HOXA13 encodes a 
DNA-binding transcription factor and may regulate gene expression, 
morphogenesis, and differentiation. It has been reported that mutated 
HOXA13 associated with the limb and genitourinary deformities development 
and can cause hand-foot-genital syndrome (Cao et al., 2017). Additionally, 
HOXD10 is expressed in the development of limb buds and is involved in 
differentiation and limb development. These limb deformities related genes 
show the similar syndrome in KBD patients, indicating their possible relation 
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to KBD. Therefore, the roles of these homeobox family genes involved in the 
development of KBD should be attended to. 
Moreover, we also confirmed other significant genes that have been 
demonstrated associated with KBD, such as TNFAIP6 and TGFBI. TNFAIP6, 
known as tumor necrosis factor alpha induced protein 6, is a member of the 
hyaluronan-binding protein family and plays an important role in ECM 
formation, inflammation and cell proliferation (S. Wang et al., 2012). Wang et al. 
(S. Wang et al., 2015) identified TNFAIP6 as a significant gene associated with 
the biological function of chondrocyte and cartilage of KBD. In addition, 
TGFBI, transforming growth factor beta induced, which encodes a collagen 
related protein to bind the type I, II, and IV collagens, plays a critical role in 
osteoblast differentiation, tissue regeneration, bone remodeling, cell collagen 
interaction, even affects bone resorption, recovery and cartilage development 
(S. Wang et al., 2012; P. Zhang et al., 2015b). TGFBI has been identified as a 
significant gene from the chondrocytic canonical pathway involved in KBD (S. 
Wang et al., 2012).  
Further GO enrichment analysis of the 298 common genes observed 
numerous GO terms involved in the development of KBD, such as cell 
adhesion, collagen, skeletal system development, cell death, apoptosis, 
cytoskeleton, ECM. Some of them have been identified playing important 
roles in the cartilage damage of KBD, like collagen and ECM. Cartilage 
contains chondrocytes as well as their surrounding ECM, which is a complex 
network formed by water, collagen, proteoglycans and other proteins. 
Collagens are the most abundant family of ECM proteins, making up 
two-thirds of the dry mass of adult articular cartilage (Y. Luo et al., 2017). 
Multiple collagen subtypes have been identified in articular cartilage, 
including the most major collagen (type II collagen) and some minor 
collagens (type IX, X, XI, VI, VII collagens). It has been known that the 
cartilage degeneration caused by abnormal catabolism in the ECM is the chief 
characteristic in the pathogenesis of KBD (X. Wang et al., 2017b). Wang et al. 
demonstrated that Wnt/β-catenin signaling pathway involved in disrupting 
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anabolism and catabolism in the ECM in KBD pathogenesis (X. Wang et al., 
2017b). Taken together, the identified GO terms may provide us important 
biological process, cellular component and molecular function involved in the 
pathogenesis of KBD.  
We identified 32 significantly modified KEGG pathways statistically 
associated with KBD, such as focal adhesion and PI3K-Akt signaling pathway. 
The focal adhesion complex is a signaling center regulating dynamic cellular 
behaviors, such as cell adhesion, spreading, migration, proliferation and 
initiated (Shin et al., 2016). Shin et al. identified inhibition of the focal 
adhesion complex could result in a significant reduction of chondrocyte 
dedifferentiation (Shin et al., 2016). Another study performing whole-exome 
sequencing found focal adhesion is a major pathway for KBD pathogenesis. 
Interestingly, focal adhesion complex is linked to the intracellular signaling 
pathway such as PI3K (Shin et al., 2016), which is a pathway that also 
identified significant in this study. PI3K is the primary signaling pathway 
regulating chondrocyte survival and apoptosis (Du et al., 2015). Du et al. 
demonstrated that SNP of Selenoprotein S SEPS1 -105G>A associated with the 
expression of PI3K-Akt signaling pathway played important roles in the 
development of KBD (Du et al., 2015). This evidence indicated that 
chondrocyte apoptosis was partly regulated by PI3K-Akt. 
It has been known that low environmental selenium has a close relation 
to KBD. Selenium, whose anti-inflammatory, antioxidant and antiviral 
properties are well known, shows biologically ambivalent characterisitics in 
animals and exerts its biological effects mainly through enzymatically active 
selenoproteins (Hoefig et al., 2011). Selenium is an integral part of 
selenoproteins, and contains the redox-active amino acid selenocysteine in 
their catalytically active center (Pallauf et al., 2006). A targeted deletion of 
tRNA gene for the selenocysteine in the osteo-chondroprogenitor cells causes 
many features similar to KBD, suggesting its potential importance for KBD 
(Downey et al., 2009). In addition, Speckmann et al. (Speckmann and Grune, 
2015) demonstrated that selenium influenced epigenetic modifications of DNA. 
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In rat liver and colon, it was suggested that selenium deficiency resulted in less 
DNA methylation mainly because selenium provides the methylation donor 
for DNA methylation (Uthus et al., 2006). In contrast, other studies showed 
that high selenium exposure decreased total DNA methylation levels in the 
liver of rats, perhaps because of selenium inhibiting DNA methyltransferase 
expression (Bermingham et al., 2013; Jablonska and Reszka, 2017). Evidences 
showed that monomethylated selenium compounds are crucial for the tumor 
preventive effects of the selenium. The methylselenolate was identified to 
interact with H2O2 and participate in the ROS of tumor formation (Gromer and 
Gross, 2002). The methylselenol is the key intermediate contributing to 
selenide in the case of selenium-methylated selenocompounds (Gromer and 
Gross, 2002; Suzuki et al., 2007).  
For the first time, we have identified selenocompound metabolism 
pathway associated with KBD via genetic study. It has been known selenium 
mainly exerts its biological effects through enzymatically active selenoproteins. 
The transport and storage of selenium are mainly depended on liver-derived 
circulating glycoprotein selenoprotein P (Hoefig et al., 2011), while 
selenoprotein S, a selenoprotein localized in the plasma membrane and 
endoplasmic reticulum (ER) stress, could control ER homeostasis and 
participate in adipogenesis (C. Y. Kim and Kim, 2018). Du et al. demonstrated 
that SNP of Selenoprotein S SEPS1 -105G>A played important roles in KBD 
pathogenesis (Du et al., 2015). Selenocompound metabolism pathway 
includes 17 genes and 27 compound of chemical substance, related to 4 
diseases (homocystinuria, hypermethioninemia, spondyloepimetaphyseal 
dysplasia[SEMD], Methylcobalamin deficiency type G), among which, SEMD 
is the most similar disease to KBD. SEME is characterized by short, bowed 
lower limbs, mild brachydactyly, enlarged knee joints, and early-onset 
osteoarthropathy, which are nearly identical to the symptom of KBD, 
suggesting that KBD and SEMD share common pathways of disease that may 
include the selenocompound metabolism pathway. Additionally, 7 genes in 
selenocompound metabolism pathway were identified significant association 
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with KBD in this study, such as CTH, SEPSECS, PAPSS2. CTH, known as 
cystathionine gamma-lyase, is a novel osteoclast regulator. Itou et al. 
identified CTH may accelerate osteoclast differentiation and has a potent 
calcium resorption function, which may serve as a molecular switch 
regulating between osteoclast and osteoblast balance (Itou et al., 2014). 
SEPSECS, whose official full name is Sep (O-phosphoserine) tRNA:Sec 
(selenocysteine) tRNA synthase, is involved in the synthesis of selenocysteine. 
It is identified as a DNA hypomethylation related gene related to KBD, and 
showed increased protein expression level in KBD cartilage tissue and 
chondrocytes in this study. Further functional studies were warranted to 
identify the interaction between SEPSECS and KBD. PAPSS2, whose official 
full name is 3'-phosphoadenosine 5'-phosphosulfate synthase 2, is also known 
as SK2, BCYM4, ATPSK2. Mutations of PAPSS2 can cause an autosomal 
recessive form of SEMD in humans (Ford-Hutchinson et al., 2005). Another 
study showed that TGF-β maintains biomechanical properties and regulates 
expression of PAPSS2 in mouse articular cartilage (Ramaswamy et al., 2012). 
The three genes mentioned above are all up-regulated in the KBD cell models 
in our study. Additionally, the mRNA expression of MMP13 was significantly 
decreased, while SOX9 expression was increased notably after knocking out 
SEPSECS in C28/I2 human chondrocytes treated with T-2 toxin. MMP13 is 
known in the breakdown of extracellular matrix in OA development. Little et 
al. found that OA progression is prohibited in MMP13 knockout mice (Little 
et al., 2009). SOX9 is found in chondrocytes differentiation. The 
overexpression of SOX9 could alleviate the progression of human OA 
(Ouyang et al., 2019). All these results indicated that the lower expression of 
SEPSECS may act a protective role in the development of KBD. Moreover, the 
increased expression of SEPSECS protein, which is recognized as 54kDa band 
by the company, also showed 43kDa notably in KBD chondrocytes. Same 
results could be found in human hepatoma cells (French et al., 2014). The in 
vitro study in KBD cartilage highlight for the first time the importance of 
selenocompound metabolism pathway in the pathogenesis of KBD. All 
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together, the identified KEGG pathways may have some potential interactions 
and give us novel insight in the development of KBD.  
Although we identified multiple genes and pathways associated with the 
development of KBD, only one pathway was confirmed by further biological 
experiments. Therefore, more functional studies are warranted to detect the 
potential mechanism of these candidate genes as well as the identified 
pathways involved in the pathogenesis of KBD.  
Conclusions 
Up to now, the pathogenesis of KBD as well as the biological effects of 
selenium in vivo are still under debate. By trans-omics analysis of 
genome-wide DNA methylation profiling and mRNA expression profiling, 
we identified 298 common genes, 36 GO terms and 32 KEGG pathways 
associated with KBD pathogenesis. Most importantly, we firstly observed the 
selenocompound metabolism pathway related to KBD via genetic study and 
verified it by validation tests. Our results have emphasized the dysfunction of 
many genes and pathways implicated in the pathogenesis of KBD and further 
confirmed the importance of selenium and selenocompound metabolism 
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Legends to Figures 
Figure 1. The barplot of GO enrichment analysis results of common genes 
altered in both DNA methylation profiles and mRNA expression profiles. BP 
stands for biological process. CC stands for cellular component. MF stands for 
molecular function.  
 
Figure 2. InCroMAP analysis results of Selenocompound metabolism 
pathway. The genes highlighted in yellow denote the genes analyzed by this 
study within the Selenocompound metabolism pathway. 
 
Figure 3. InCroMAP analysis results of PI3K-ATK signaling pathway. The 
genes highlighted in yellow denote the genes analyzed by this study within 
the PI3K-ATK signaling pathway. 
 
Figure 4. The mRNA expression of SEPSECS (A), CTH (B), PAPSS2 (C) in 
C28/I2 in KBD cell models. The x-axis indicates different T-2 toxin 
intervention concentrations. The y-axis represents the mRNA expression 
levels of the genes compared to normal control. **** means P < 0.0001, and ** 
means P < 0.01.  
 
Figure 5. The mRNA expression of SEPSECS (A), MMP13 (B), SOX9 (C) and 
ADAMTS5 (D) in C28/I2 in KBD cell models. The y-axis represents the 
mRNA expression levels of the genes compared to normal control. *** means 
P < 0.001, ** means P < 0.01, * means P < 0.05. 
 
Figure 6. The expression of SEPSECS protein in the KBD and control cartilage. 
Immunostaining for SEPSECS in the superficial, middle and deep zone of 
KBD cartilage (A). The percentage of positive of SEPSECS in the superficial 
(B), middle (C), deep layer (D) of KBD and control cartilage. *P=0.021 in the 




Figure 7. The expression of SEPSECS protein in the KBD and control 
chondrocytes. The expression of SEPSECS protein in KBD chondrocytes and 




Table1. Basic characteristics of study samples 




Western Blot IHC 
Samples Control KBD Control KBD Control KBD Control KBD 
Number 5 5 4 4 5 5 3 3 
Age(Mean±SD) 51.0±7.3 57.4±7.1 48.5±8.3 49.5±5.6 66.2±13.6 57.4±8.0 54.0±16.1 53.0±3.0 




Table 2 The primers used for qPCR 
Gene Forward Reverse 
SEPSECS 5'-GGCTGTGGCAGTGTGCTTAGAA-3′ 5'-TCCTAAGGCTGGCGTCACATATC-3′ 
CTH 5'-ATCCACAGCATGAGTTGGTGAAG-3′ 5'-CCAAGCTCTCGGCCAGAGTAAATA-3′ 
PAPSS2 5'-AATGTGGCGATGTCGTGGA-3′ 5'-TGCCTTGCTAGTCTGATAGTGTGAA-3′ 
MMP13 5'-TCCCAGGAATTGGTGATAAAGTAGA-3′ 5'-GCATGACGCGAACAATACGG-3′ 
SOX9 5'-GGAGATGAAATCTGTTCTGGGAATG-3′ 5'-TTGAAGGTTAACTGCTGGTGTTCTG-3′ 
ADAMTS5 5'-TCAGCTTTGGCAACCTTCAAATC-3′ 5'-AGGTCCCAAACGGCTCAGTTC-3′ 





Table 3 The top 20 significant hypermethylation and hypomethylation CpG sites 
Type CpG cite P-value Padj-value ∆β Gene 
Hypermethylation cg07687119 3.11×10-9 3.69×10-4 0.345 HOXC4;HOXC6;HOXC5 
 cg13763232 6.29×10-9 5.96×10-4 0.2436 SLC6A6 
 cg18503031 3.09×10-8 2.44×10-3 0.2958 MITF 
 cg05401764 5.89×10-8 2.94×10-3 0.5756 SHOX2 
 cg01214458 9.79×10-8 3.26×10-3 0.2028 MN1 
 cg01410314 1.03×10-7 3.26×10-3 0.2048 C9orf41 
 cg01575836 1.23×10-7 3.26×10-3 0.4202  
 cg24937727 1.58×10-7 3.26×10-3 0.3358 RGL3 
 cg07464206 2.15×10-7 3.60×10-3 0.3282  
 cg06359632 2.33×10-7 3.60×10-3 0.442  
 cg15964309 2.34×10-7 3.60×10-3 0.3868  
 cg10928103 2.73×10-7 3.60×10-3 0.3786  
 cg17848054 3.09×10-7 3.60×10-3 0.241 RGL3 
 cg00862290 4.08×10-7 3.86×10-3 0.4134 KCNMB3 
 cg20266894 4.08×10-7 3.86×10-3 0.401  
 cg22799141 5.05×10-7 4.05×10-3 0.3512  
 cg04403850 5.13×10-7 4.05×10-3 0.3178  
 cg02532853 5.68×10-7 4.13×10-3 0.2698 NCRNA00114 
 cg03255182 5.86×10-7 4.13×10-3 0.301 HOXC4;HOXC6;HOXC5 
 cg04875697 6.00×10-7 4.13×10-3 0.2044 RXRA 
Hypomythylation cg03223172 1.28×10-9 3.04×10-4 -0.294  
 cg16549994 6.88×10-8 2.94×10-3 -0.2026  
 cg19291576 6.90×10-8 2.94×10-3 -0.3832  
 cg27159719 7.45×10-8 2.94×10-3 -0.2292 TMEM71 
 cg21400851 1.40×10-7 3.26×10-3 -0.308 KCTD2 
 cg22786333 1.52×10-7 3.26×10-3 -0.2962 HEATR2 
 cg24193140 1.84×10-7 3.53×10-3 -0.3038 KCTD16 
 cg15058852 1.99×10-7 3.53×10-3 -0.3516 GNS 
 cg00347729 2.62×10-7 3.60×10-3 -0.292 MMP10 
 cg14378231 2.69×10-7 3.60×10-3 -0.4056  
 cg27050407 2.84×10-7 3.60×10-3 -0.611 FAM65B 
 cg20746459 3.00×10-7 3.60×10-3 -0.4686 C1orf125;NPHS2 
 cg09501687 3.05×10-7 3.60×10-3 -0.3636 C5orf62 
 cg01420491 3.12×10-7 3.60×10-3 -0.2736 HS1BP3 
 cg07954691 3.23×10-7 3.65×10-3 -0.514  
 cg09060914 4.14×10-7 3.86×10-3 -0.4484 SELP 
 cg12302621 4.52×10-7 3.91×10-3 -0.2294 SLC28A1 
 cg06133897 4.58×10-7 3.91×10-3 -0.212  
 cg22659564 4.66×10-7 3.91×10-3 -0.24 FAT3 
 cg21332304 5.23×10-7 4.06×10-3 -0.3174 NPEPPS 
Note: ∆β>0,hypermethlation; ∆β<0, hypomethlation. 
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Table 4. Integrated pathway enrichment analysis results 
KEGG ID Pathway name P-value 




Genes in KBD 
hsa05200 Pathways in cancer 6.14×10-4 526 91 
hsa04510 Focal adhesion 7.03×10-4 199 56 
hsa04151 PI3K-Akt signaling pathway 3.40×10-3 354 82 
hsa04810 Regulation of actin cytoskeleton 3.95×10-3 213 55 
hsa04350 TGF-beta signaling pathway 4.30×10-3 84 25 
hsa04512 ECM-receptor interaction 5.43×10-3 82 25 
hsa04144 Endocytosis 6.50×10-3 244 50 
hsa00010 Glycolysis / Gluconeogenesis 6.98×10-3 68 17 
hsa05205 Proteoglycans in cancer 8.00×10-3 203 56 
hsa01200 Carbon metabolism 8.35×10-3 63 26 
hsa05169 Epstein-Barr virus infection 8.64×10-3 201 53 
hsa04141 
Protein processing in endoplasmic 
reticulum 
1.01×10-2 165 47 
hsa05222 Small cell lung cancer 1.21×10-2 93 26 
hsa00450 Selenocompound metabolism 1.23×10-2 17 7 
hsa04390 Hippo signaling pathway 1.27×10-2 154 38 
hsa04530 Tight junction 1.41×10-2 170 27 
hsa05215 Prostate cancer 1.41×10-2 97 27 
hsa05202 Transcriptional misregulation in cancer 1.43×10-2 186 50 
hsa04730 Long-term depression 1.55×10-2 60 18 
hsa04670 Leukocyte transendothelial migration 1.62×10-2 112 28 
hsa04710 Circadian rhythm 1.63×10-2 31 11 
hsa00620 Pyruvate metabolism 2.33×10-2 39 12 
hsa00380 Tryptophan metabolism 2.40×10-2 40 14 
hsa00562 Inositol phosphate metabolism 2.40×10-2 74 15 
hsa05213 Endometrial cancer 2.91×10-2 58 16 
hsa05218 Melanoma 2.91×10-2 72 16 
hsa05014 Amyotrophic lateral sclerosis (ALS) 3.39×10-2 51 17 
hsa05219 Bladder cancer 3.66×10-2 41 14 
hsa05100 Bacterial invasion of epithelial cells 3.72×10-2 74 19 
hsa00020 Citrate cycle (TCA cycle) 3.81×10-2 30 10 
hsa05221 Acute myeloid leukemia 4.59×10-2 66 17 
hsa00532 
Glycosaminoglycan biosynthesis - 
chondroitin sulfate/dermatan sulfate 
4.88×10-2 20 8 
 
